I-Bridge Capital, BioLineRX launch drug development JV in China

I-Bridge Capital, BioLineRX launch drug development JV in China

Image from BioLineRX website

Chinese healthcare-focussed venture capital firm I-Bridge Capital has teamed up with Israeli biopharma firm BioLineRX Ltd to form a new drug development player in China.

Bring stories like this into your inbox every day.

Sign up for our newsletter - The Daily Brief
Subscribe to Newsletter